Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 87500 88882

Blog Standard

How US Tariffs Will Impact Healthcare & Pharma in 2025: What You Need to Know

Insights Details Month: Jun 25 Tags: Tariff, Conference, USA, China, Import, Export, Tariff impact, Investment, Company Profile, Product profile, Tailwind, Headwind, Landscape, Pfizer, Johnson & Johnson, Roche, BMS, Eli lilly, Novartis, Sanofi, Merck, Abbvie, AstraZeneca Let’s Work Together for Development Call us directly, submit a sample or email us! Business Address First Floor, B-66, Sector […]
Continue Reading

Learning from Trial Failures: Turning Setbacks into Strategic Data Assets

Every company has a “Phase III heartbreak.” The molecule looked perfect-mechanism sound, safety profile strong- but the primary endpoint missed. Most teams bury the data. At Octavus Consulting, we treat it as a gold mine. The Opportunity in Failure Clinical failures hold information about trial design, recruitment, and patient heterogeneity that can redefine the next […]
Continue Reading

Strategic Intelligence in Biopharma M&A: Seeing the Deal Before It Happens

When Gilead acquired Forty Seven Inc. in 2020, most observers called it quick. Those who tracked macrophage checkpoint research knew it was inevitable. That’s the power of strategic intelligence-not reacting to news, but foreseeing inevitabilities. At Octavus Consulting, we help clients move from rumor-driven scouting to a pattern-based acquisition strategy. In 2025’s market, where capital […]
Continue Reading

Real-World Evidence 2.0: From Post-Market Validation to Strategic Design

In 2025, Real-World Evidence (RWE) is no longer an afterthought in regulatory filings. It’s a design principle. We recently worked with a biotech firm developing an oncology therapy, struggling with limited trial enrollment and payer skepticism. Instead of waiting until post-launch to demonstrate real-world value, they embedded RWE from day one. By integrating claims and […]
Continue Reading

Subscribe Newsletter

Sign up to receive notifications about the latest news and events from us!